Dec 19 (Reuters) - Cyclopharm Ltd (CYC) :
- FY18 REVENUE EXPECTED TO BE IN LINE WITH FY17
- CO RECONFIRMS IT WILL HAVE SUFFICIENT CASH TO COMPLETE USFDA SUBMISSION, FUND RESEARCH AND DEVELOPMENT AND NEAR TERM GROWTH INITIATIVES
News: CYC Cyclopharm Says FY18 Revenue Expected To Be In Line With FY17
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
-0.020(1.45%) |
Mkt cap ! $166.7M | |||
| Open | High | Low | Value | Volume |
| $1.38 | $1.40 | $1.36 | $59.10K | 42.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 369 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 1722 | 1 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| CYC (ASX) Chart |
